IP Verse

G. L. Pharma Gmbh opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by G. L. Pharma Gmbh

Patent Number:
EP2653873
Title:
Compositions And Uses For Treating Multiple Sclerosis
Applicant:
BIOGEN IDEC MA INC.
Opposition Date:
Oct 10, 2022
Patent Number:
EP3656765
Title:
Salts Or Co-Crystals Of 3-(3-Dimethylamino-1-Ethyl-2-Methyl-Propyl)-Phenol
Applicant:
GRÜNENTHAL GMBH
Opposition Date:
Apr 15, 2021
Patent Number:
EP3199172
Title:
Dosing Regimen For Multiple Sclerosis
Applicant:
YEDA RESEARCH AND DEVELOPMENT CO., LTD.
Opposition Date:
Apr 11, 2019
Patent Number:
EP2630962
Title:
Low Frequency Glatiramer Acetate Therapy
Applicant:
YEDA RESEARCH & DEVELOPMENT COMPANY, LTD.
Opposition Date:
Mar 26, 2019
Patent Number:
EP1845956
Title:
Break-Resistant Delayed-Release Forms Of Administration
Applicant:
GRÜNENTHAL GMBH
Opposition Date:
Dec 19, 2017
Patent Number:
EP2425821
Title:
Pharmaceutical Preparation Containing Oxycodone And Naloxone
Applicant:
EURO-CELTIQUE S.A.
Opposition Date:
Nov 9, 2017
Patent Number:
EP2425824
Title:
Pharmaceutical Preparation Containing Oxycodone And Naloxone
Applicant:
EURO-CELTIQUE S.A.
Opposition Date:
Nov 9, 2017
Patent Number:
EP2949335
Title:
Low Frequency Glatiramer Acetate Therapy
Applicant:
YEDA RESEARCH & DEVELOPMENT COMPANY, LTD.
Opposition Date:
Oct 4, 2017

Competitors of G. L. Pharma Gmbh

EURO-CELTIQUE S.A.

GRÜNENTHAL GMBH

MUNDIPHARMA AB

Want to track G. L. Pharma Gmbh?

Feel free to send us a message here and we will get back to you